Clinical Trial of Autologous Tcm Immunotherapy in ICC

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Cholangiocarcinoma
Interventions
BIOLOGICAL

autologous Tcm cellular immunotherapy

autologous cellular immunotherapy plus traditional therapy. • cells will be infused in 3-5×109 cells/100 ml 1 month after radical resection, then cells will be infused as the same dose followed by a 1 month rest period, Each subject in experimental group will receive a total of 5 cell infusions.

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Newish Technology (Beijing) Co., Ltd.

INDUSTRY